In our study, all cases were of LS-associated sarcomas and presented with MSH2 germline variations and MSH2/MSH6 protein-expression deficiency; these features are similar to the molecular features of similar tumors reported in the literature (21). The gene discussed is MSH2; the disease is sarcoma.